4 European Projects Found
Searched on 125080 European Projects
FINISHED
Addictions and Lifestyles In Contemporary Europe – Reframing Addictions Project (ALICE RAP)
Start date: Apr 1, 2011, End date: Mar 31, 2016,
ALICE RAP is a Europe wide project of 43 partner research institutions involving 107 researchers from 25 European countries providing 1000 months of a plurality of scientific endeavour to analyse the place and challenges of addictions and lifestyles to the cohesion, organization and functioning of contemporary European society. Through integrated multidisciplinary research, a wide range of factors ...
Read Project
46
Partners Participants
FINISHED
Structural Transformation to Achieve Gender Equality in Science (STAGES)
Start date: Jan 1, 2012, End date: Dec 31, 2015,
STAGES has the general aim of making the most of the unprecedented opportunity, provided for by the EC, to leave the logic of pilot projects behind and launch structural change strategies addressing the many and interconnected layers of the problem of gender inequality in science from an integrated perspective, deeply involving human resources management in research institutions, modifying and gen ...
Read Project
7
Partners Participants
FINISHED
Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia (CRESTAR)
Start date: Nov 1, 2011, End date: Oct 31, 2015,
Treatment resistant schizophrenia (TRS) is the most disabling of all psychiatric illnesses, affecting about 1/3 of patients (~1 million Europeans), a considerable economic and social burden. First-line treatments include atypical (e.g. olanzapine) and typical (e.g. haloperidol) antipsychotics. The original atypical, clozapine, is a final option, and although it is the only antipsychotic shown to b ...
Read Project
11
Partners Participants
FINISHED
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)
Start date: Sep 1, 2009, End date: Apr 30, 2015,
Recent pharmacovigilance (PV) issues have led to questions regarding the ability of the current PV system to meet the global needs. Controversies around the assessment of spontaneous reports and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Age ...
Read Project
